Small-cap companies often sit outside the spotlight but that’s exactly where the biggest opportunities can emerge. With valuations under $2 billion, these firms combine early-stage growth with market inefficiencies that large funds often overlook. While volatility is higher, the upside can be significantly greater for investors willing to dig deeper. This selection highlights three companies that could benefit from structural trends and future capital inflows.

Small and mid-sized companies with market capitalizations of less than $2 billion are probably the least explored space in the U.S. stock market. Large institutions often ignore them and liquidity is lower. However, this is precisely what can be an advantage for investors who can identify these companies before their market capitalization begins to rise steeply.

Each of the three selected companies operates in a radically different segment. Axogen is a manufacturer of surgical products. Polestar is a Swedish electric car…